Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2209

1.

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti CE, Cassano GB.

J Clin Psychiatry. 2003 Apr;64(4):451-8.

PMID:
12716249
[PubMed - indexed for MEDLINE]
2.

Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.

Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB.

J Clin Psychiatry. 2000 May;61(5):329-34.

PMID:
10847306
[PubMed - indexed for MEDLINE]
3.

Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.

Narendran R, Young CM, Valenti AM, Pristach CA, Pato MT, Grace JJ.

J Clin Psychiatry. 2001 Jul;62(7):509-16.

PMID:
11488360
[PubMed - indexed for MEDLINE]
4.

Predictors of response in a sample of treatment-resistant psychotic patients on clozapine.

Ciapparelli A, Ducci F, Carmassi C, Carlini M, Paggini R, Catena M, Bottai M, Dell'Osso L.

Eur Arch Psychiatry Clin Neurosci. 2004 Oct;254(5):343-6.

PMID:
15365711
[PubMed - indexed for MEDLINE]
5.

Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.

Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ.

Am J Psychiatry. 1999 Aug;156(8):1164-9.

PMID:
10450255
[PubMed - indexed for MEDLINE]
6.

Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

Banov MD, Zarate CA Jr, Tohen M, Scialabba D, Wines JD Jr, Kolbrener M, Kim JW, Cole JO.

J Clin Psychiatry. 1994 Jul;55(7):295-300.

PMID:
8071290
[PubMed - indexed for MEDLINE]
7.

Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.

McElroy SL, Dessain EC, Pope HG Jr, Cole JO, Keck PE Jr, Frankenberg FR, Aizley HG, O'Brien S.

J Clin Psychiatry. 1991 Oct;52(10):411-4.

PMID:
1938976
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
[PubMed - indexed for MEDLINE]
9.

Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.

Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.

J Clin Psychiatry. 2004 Dec;65(12):1624-33.

PMID:
15641867
[PubMed - indexed for MEDLINE]
10.

Clozapine for treatment-refractory mania.

Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY.

Am J Psychiatry. 1996 Jun;153(6):759-64.

PMID:
8633686
[PubMed - indexed for MEDLINE]
11.

Clozapine treatment in a population of adults with mental retardation.

Antonacci DJ, de Groot CM.

J Clin Psychiatry. 2000 Jan;61(1):22-5.

PMID:
10695641
[PubMed - indexed for MEDLINE]
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
13.

Is clozapine a mood stabilizer?

Zarate CA Jr, Tohen M, Banov MD, Weiss MK, Cole JO.

J Clin Psychiatry. 1995 Mar;56(3):108-12.

PMID:
7883728
[PubMed - indexed for MEDLINE]
14.

Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.

Stewart M, DelBello MP, Versavel M, Keller D.

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):635-40. doi: 10.1089/cap.2008.0158.

PMID:
20035581
[PubMed - indexed for MEDLINE]
15.

Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features.

Pini S, de Queiroz V, Dell'Osso L, Abelli M, Mastrocinque C, Saettoni M, Catena M, Cassano GB.

Eur Psychiatry. 2004 Feb;19(1):8-14.

PMID:
14969775
[PubMed - indexed for MEDLINE]
16.

Clinical effects of a randomized switch of patients from clozaril to generic clozapine.

Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K.

J Clin Psychiatry. 2001;62 Suppl 5:14-7; discussion 23-4.

PMID:
11305843
[PubMed - indexed for MEDLINE]
17.

EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.

Pillay SS, Stoll AL, Weiss MK, Tohen M, Zarate CA Jr, Banov MD, Cole JO.

Ann Clin Psychiatry. 1996 Mar;8(1):1-5.

PMID:
8743641
[PubMed - indexed for MEDLINE]
18.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
[PubMed - indexed for MEDLINE]
19.

Quetiapine alone and added to a mood stabilizer for serious mood disorders.

Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR.

J Clin Psychiatry. 2001 Sep;62(9):728-32.

PMID:
11681770
[PubMed - indexed for MEDLINE]
20.

Diagnostic stability 18 months after treatment initiation for first-episode psychosis.

Schimmelmann BG, Conus P, Edwards J, McGorry PD, Lambert M.

J Clin Psychiatry. 2005 Oct;66(10):1239-46.

PMID:
16259537
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk